NCT07052331 The MOBY Study: Efficacy of Birth Mobility
| NCT ID | NCT07052331 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Vibwife AG |
| Condition | Labor Duration |
| Study Type | INTERVENTIONAL |
| Enrollment | 714 participants |
| Start Date | 2025-07-25 |
| Primary Completion | 2028-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 714 participants in total. It began in 2025-07-25 with a primary completion date of 2028-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized clinical trial investigates whether and how maternal mobility during labor influences birth outcomes in primiparous women. The study compares standard obstetric care with care that includes a birth mobility system. The primary aim is to assess whether the system helps reduce secondary cesarean section rates. Secondary objectives include evaluation of labor progression, medication use, newborn health, and user satisfaction. Participation occurs during birth and includes the collection of routine clinical data and a short questionnaire afterward.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years * German- or English-speaking * Able to provide written informed consent with capacity of judgment * Low-risk singleton pregnancy * Primiparous woman * Cephalic presentation * Gestational age at delivery ≥ 37 + 0 weeks Exclusion Criteria: * Multiparous woman * Not capable of understanding instructions for use of the mobility system (intervention group) * Scheduled (elective) cesarean section * Contraindication to vaginal delivery * Multiple pregnancy * Breech presentation * Estimated fetal weight \< 10th percentile or \> 90th percentile * Relevant fetal congenital abnormalities affecting neonatal adaptation * Pre-existing medical conditions significantly affecting mobility (e.g., orthopedic conditions, osteoporosis, multiple sclerosis, spinal cord injury) * Relevant intrapartum bleeding * Preeclampsia or HELLP syndrome
Contact & Investigator
Prof. Dr. med. Leonhard Schäffer
PRINCIPAL INVESTIGATOR
Kantonsspital Baden
Frequently Asked Questions
Who can join the NCT07052331 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Labor Duration. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07052331 currently recruiting?
Yes, NCT07052331 is actively recruiting participants. Contact the research team at leonhard.schaeffer@ksb.ch for enrollment information.
Where is the NCT07052331 trial being conducted?
This trial is being conducted at Baden, Switzerland.
Who is sponsoring the NCT07052331 clinical trial?
NCT07052331 is sponsored by Vibwife AG. The principal investigator is Prof. Dr. med. Leonhard Schäffer at Kantonsspital Baden. The trial plans to enroll 714 participants.